(Reuters) - European shares slipped on Friday after a rally in the previous session spurred by U.S. Federal Reserve's ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

North Carolina’s senators are both calling for increased security protection for former President Donald Trump after a ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), ...

The Marseille-based company has been awarded nondilutive public funding of €20.18 million (US$22.4 million) as part of the €54 billion France 2030 strategy, which aims to restore the country’s ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s ...

OnlyFans model Lottie Moss said on her podcast that the experience was "one of the scariest things that's ever happened to me in my life." ...

A weight loss drug has been found to be broadly safe and effective for children under 12 with obesity, according to a small ...

People taking semaglutide for type 2 diabetes and/or weight control could have to take the medication just once a month, thanks to development of a monthly shot that contains a hydrogel.